We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
-15.04%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.93B
AUM Growth
-$2.01B
Cap. Flow
-$404M
Cap. Flow %
-5.09%
Top 10 Hldgs %
39.56%
Holding
93
New
5
Increased
31
Reduced
42
Closed
5

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$199M
2
JPM icon
JPMorgan Chase
JPM
+$104M
3
MRK icon
Merck
MRK
+$101M
4
EQIX icon
Equinix
EQIX
+$61M
5
CL icon
Colgate-Palmolive
CL
+$57M

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Financials 14.65%
3 Healthcare 13.45%
4 Industrials 12.04%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHTR icon
26
Charter Communications
CHTR
$17.3B
$118M 1.48%
250,971
-3,044
-1% -$1.48M
FRC
27
DELISTED
First Republic Bank
FRC
$117M 1.48%
811,757
+78,405
+11% +$11.8M
AVGO icon
28
Broadcom
AVGO
$1.85T
$117M 1.47%
2,401,320
-94,960
-4% -$5.33M
NATI
29
DELISTED
National Instruments Corp
NATI
$115M 1.45%
3,691,110
+344,391
+10% +$12.2M
ACWI icon
30
iShares MSCI ACWI ETF
ACWI
$32.9B
$109M 1.38%
1,300,488
-1,950
-0.1% -$177K
CCI icon
31
Crown Castle
CCI
$33.3B
$105M 1.32%
623,155
+25,779
+4% +$4.69M
UPS icon
32
United Parcel Service
UPS
$88.6B
$105M 1.32%
572,732
+17,463
+3% +$3.19M
CSCO icon
33
Cisco
CSCO
$457B
$101M 1.28%
2,377,753
+1,660,645
+232% +$79.5M
MPT
34
Medical Properties Trust
MPT
$2.77B
$101M 1.27%
6,617,088
+1,363,968
+26% +$24.5M
SIVB
35
DELISTED
SVB Financial Group
SIVB
$99.8M 1.26%
252,622
-3,631
-1% -$1.71M
MCO icon
36
Moody's
MCO
$82.8B
$97.6M 1.23%
358,739
-5,033
-1% -$1.51M
JKHY icon
37
Jack Henry & Associates
JKHY
$10.9B
$88.6M 1.12%
492,286
-174,629
-26% -$32.7M
BLK icon
38
Blackrock
BLK
$169B
$74.4M 0.94%
122,202
-777
-0.6% -$506K
ATVI
39
DELISTED
Activision Blizzard
ATVI
$61.9M 0.78%
795,606
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.36T
$58.8M 0.74%
539,200
-133,620
-20% -$15.7M
PLD icon
41
Prologis
PLD
$135B
$48.8M 0.62%
415,198
+108,132
+35% +$14.9M
TFX icon
42
Teleflex
TFX
$6.05B
$48.2M 0.61%
195,908
+3,049
+2% +$889K
BKNG icon
43
Booking.com
BKNG
$149B
$45.4M 0.57%
649,525
+117,700
+22% +$10M
WY icon
44
Weyerhaeuser
WY
$18B
$35.8M 0.45%
1,081,416
-141,512
-12% -$5.4M
META icon
45
Meta Platforms (Facebook)
META
$1.42T
$34M 0.43%
210,919
SEE
46
DELISTED
Sealed Air
SEE
$32.9M 0.42%
570,456
-155,589
-21% -$9.82M
EBAY icon
47
eBay
EBAY
$50.6B
$30.5M 0.38%
730,892
FMX icon
48
Fomento Económico Mexicano
FMX
$43.6B
$29.7M 0.38%
440,642
ENTG icon
49
Entegris
ENTG
$18.1B
$29.4M 0.37%
319,193
+3,170
+1% +$344K
PYPL icon
50
PayPal
PYPL
$48.9B
$29M 0.37%
415,015
+3,728
+0.9% +$323K

Similar funds

Sarasin & Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Sarasin & Partners held 93 positions worth $7.93B, down 20% from $9.95B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sarasin & Partners withdrew a net $404M in Q2 2022, closing 5 positions and reducing 42 holdings. Its most notable exit was Marriott International, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sarasin & Partners opened a new position in Edwards Lifesciences worth $24.1M.

  • Sarasin & Partners's largest Q2 2022 buy was Edwards Lifesciences: 253,530 shares worth $24.1M.
  • Sarasin & Partners added most to International Flavors & Fragrances in Q2 2022, an estimated $174M increase.
  • Sarasin & Partners's biggest Q2 2022 reduction was JPMorgan Chase, cutting an estimated $104M.
  • Sarasin & Partners fully exited Marriott International in Q2 2022, selling an estimated $199M.
  • Sarasin & Partners's ten largest holdings make up 40% of its $7.93B portfolio in Q2 2022.
  • Sarasin & Partners opened 5 new positions and closed 5 in Q2 2022.
  • Sarasin & Partners's portfolio value fell 20% quarter-over-quarter to $7.93B.

Based on Sarasin & Partners's 13F filing for Q2 2022, filed 13 Jul 2022.